Accessibility List
Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

  1. Home
Market Nav

MARKSANS PHARMA LTD.

  • NSE CodeMARKSANSEQ
  • BSE Code524404
  • ISININE750C01026
  • IndustryPharmaceuticals

Company Information

Management

Incorporation Year

16/04/1992

Registered Address

Registered Office : 11th Floor, Grandeur, Veera Desai Extension Road, Oshiwara, Andheri (West),
Mumbai, Maharashtra - 400053
Tel: 022-40012000
Fax: 022-40012011

Registrar Office

Bigshare Services Pvt. Ltd.
S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Ma
Mumbai,400093,Maharashtra
Tel: 022-62638200
Fax: 62638261

Email

companysecretary@marksanspharma.com

Website

http://www.marksanspharma.com

Listing

BSE, BSE, NSE

Corporate News

Marksans Pharma - Analysts/Institutional Investor Mee...

27-May-2026|6:54PM

Marksans Pharma Limited has informed the Exchange about Audio Recording of

Marksans Pharma - Announcement under Regulation 30 (L...

27-May-2026|6:52PM

Audio Recording of investor(s) / analyst(s) meet Conference Call on Q4 FY26

Marksans Pharma - Copy of Newspaper Publication

27-May-2026|5:59PM

Marksans Pharma Limited has informed the Exchange about Copy of Newspaper P

Marksans Pharma - Corporate Action-Board approves Div...

26-May-2026|1:35PM

The Board has recommended Dividend of Rs. 0.90 per share subject to approva

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug77.99221.14
Aarti Drug380.403,471.91
Aarti Pharma633.255,740.90
Abbott India26,855.0057,065.00
Accent Micro441.951,060.19
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
Bandhan..65.090.26
UTI Sma..59.201.21
Kotak S..48.523.40
UTI Agg..43.250.66
UTI Lar..40.910.69
More

Board Meetings

DatePurpose
26/05/2026Audited Results & F..
05/02/2026Quarterly Results
13/11/2025Quarterly Results
12/08/2025Quarterly Results
19/05/2025Audited Results & F..
More